INIS
kidneys
100%
patients
93%
diseases
66%
dialysis
50%
transplants
36%
coronaviruses
34%
covid-19
34%
therapy
27%
risks
18%
populations
17%
comparative evaluations
17%
levels
16%
control
15%
quality of life
13%
antibodies
13%
europe
12%
netherlands
10%
mortality
10%
symptoms
9%
albuminuria
9%
screening
8%
data
8%
vaccines
8%
units
7%
implementation
6%
edta
5%
grafts
5%
design
5%
failures
5%
Keyphrases
COVID-19
39%
Kidney Transplant Recipients
36%
Chronic Kidney Disease
27%
Kidney Replacement Therapy
25%
Dialysis Patients
24%
Renal Association
22%
Dutch
20%
Kidney Transplantation
17%
Dialysis
17%
COVID-19 Data
15%
Health-related Quality of Life
13%
Europe
12%
Vaccination
12%
Patient-Reported Outcomes Measurement Information System (PROMIS)
11%
Netherlands
11%
Risk Factors
9%
Albuminuria
9%
Illness Perceptions
8%
Hemodialysis
8%
Antibody Level
8%
COVID-19 Pandemic
8%
Chronic Kidney Disease Stage
7%
Kidney Failure
7%
Multicenter Randomized Controlled Trial
7%
Hemodialysis Patients
7%
Home-based Screening
7%
Kidney Disease Progression
6%
Kidney Disease
6%
Dialysis Care
6%
SARS-CoV-2 Vaccination
6%
Medicine and Dentistry
COVID-19
40%
Kidney Graft
32%
Renal Replacement Therapy
27%
Chronic Kidney Disease
25%
Hemodialysis
21%
Kidney Transplantation
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Nephropathy
11%
Quality of Life
11%
COVID-19 Vaccination
9%
Randomized Controlled Trial
8%
Peritoneal Dialysis
8%
Kidney Function
8%
Mental Health
7%
Immune Response
7%
Intensive Care Unit
7%
Triage
6%
Renal Failure
6%
Albuminuria
5%
Health Outcomes
5%
B Cell
5%
Diseases
5%
Prevalence
5%
Messenger RNA
5%